Postdoctoral Research Fellow
PhD
Dr Wang is an emerging leader in the field of nucleic acid (DNA/RNA) chemistry and anti-cancer drug development, with 49 publications and over 2,300 citations since he received his PhD degree in 2015.
His research in functional nucleic acid research attracted wide media coverage locally and nationally (ABC News & The West Australian). Recently, he was awarded the 2022 Raine priming grant.
Find Dr Wang on ORCID.
-
Publications
February 2024
Supportive care needs and associated factors among caregivers of patients with colorectal cancer: a cross-sectional study
To assess the level of supportive care needs of caregivers of colorectal cancer patients and explore the related key influencing factors. Totaling 283 caregivers of patients with colorectal cancer were investigated in this study.
Published research Sarcoma Translational Research Cancers (other)February 2024Post-surgery financial toxicity and its influencing factors in colorectal cancer care: A cross-sectional study
This study aimed to investigate the influence factors of financial toxicity experienced by colorectal cancer patients after surgery. The results will provide deep insights for developing effective intervention strategies to address this common issue of colorectal cancer care.
Published research Sarcoma Translational Research Cancers (other)January 2024Caregiver burden, mutuality, and family resilience in colorectal cancer caring: A mediating model analysis
This study investigates the interaction between caregiver burden, mutuality, and family resilience in colorectal cancer management, and determines whether mutuality affects the effect of caregiver burden on family resilience.
Published research Subsite: Cancer Sarcoma Translational Research Cancers (other)December 2023A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC
Esophageal squamous cell carcinoma (ESCC) is a prevalent malignant tumor of the digestive tract with a low 5-year survival rate due to the lack of effective treatment methods. Although therapeutic monoclonal antibodies (mAbs) now play an important role in cancer therapy, effective targeted mAbs are still lacking for ESCC.
Published research Sarcoma Translational Research Cancers (other)February 2023Glutamine Deprivation Synergizes the Anticancer Effects of Cold Atmospheric Plasma on Esophageal Cancer Cells
Esophageal cancer is a highly aggressive malignancy with a low response to standard anti-cancer therapies. There is an unmet need to develop new therapeutic strategies to improve the clinical outcomes of current treatments. Cold atmospheric plasma (CAP) is a promising approach for cancer treatment, and has displayed anticancer efficacy in multiple preclinical models. Recent studies have shown that the efficacy of CAP is positively correlated with intracellular reactive oxygen species (ROS) levels.
Children's Cancers Published research Sarcoma Translational Research -
Education and Qualifications